Pulmonx LUNG
NASDAQ LUNG
$1.83 -0.08 (-4.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pulmonx (LUNG) Gains from Sales and Divestitures (2022 - 2023)

Updated

Pulmonx (LUNG) recorded Gains from Sales and Divestitures of -$4,000 in Q4 2023.

Analysis

Pulmonx (LUNG) Gains from Sales and Divestitures (2022 - 2023) Analysis & Trends

For FY2023, Pulmonx reported Gains from Sales and Divestitures of $15,000.

  • Across earlier years, Gains from Sales and Divestitures came in at -$7,000 in FY2022.
  • The Q4 2023 figure is the lowest quarterly Gains from Sales and Divestitures since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Pulmonx 76.26 Mn -242.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -4,000.00
Sep 30, 2023 20,000.00
Mar 31, 2023 -1,000.00
Sep 30, 2022 -6,000.00
Jun 30, 2022 -1,000.00
API Access

Pulmonx Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=LUNG&period=max&api_key=YOUR_API_KEY